BF
SRPT icon

BOK Financial’s Sarepta Therapeutics SRPT Stock Holding History

BOK Financial’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$17 – 1203
2025
Q2 		$17 Sell
1
-2,694
-100% -$115K ﹤0.01% 1145
2025
Q1 		$172K Sell
2,695
-9,297
-78% -$979K ﹤0.01% 717
2024
Q4 		$1.5M Buy
11,992
+11,990
+599,500% +$1.47M 0.03% 389
2024
Q3 		$238 Hold
2
– – ﹤0.01% 1327
2024
Q2 		$316 Sell
2
-14
-88% -$1.8K ﹤0.01% 1126
2024
Q1 		$2.05K Buy
16
+14
+700% +$1.72K ﹤0.01% 1060
2023
Q4 		$192 Sell
2
-12
-86% -$1.15K ﹤0.01% 1239
2023
Q3 		$942 Buy
+14
New +$1.58K ﹤0.01% 1090
2023
Q2 		– Sell
-132
Closed -$18.2K – 1171
2023
Q1 		$18.2K Buy
+132
New +$17.1K ﹤0.01% 939
2021
Q1 		– Sell
-29,288
Closed -$4.99M – 949
2020
Q4 		$4.99M Buy
29,288
+9,114
+45% +$1.35M 0.1% 204
2020
Q3 		$2.83M Sell
20,174
-3,048
-13% -$463K 0.06% 265
2020
Q2 		$3.72M Sell
23,222
-1,013
-4% -$138K 0.09% 218
2020
Q1 		$2.37M Buy
24,235
+5,078
+27% +$580K 0.07% 260
2019
Q4 		$2.47M Buy
+19,157
New +$1.93M 0.06% 311
2019
Q3 		– Sell
-26,415
Closed -$4.01M – 942
2019
Q2 		$4.01M Buy
26,415
+4,694
+22% +$570K 0.1% 226
2019
Q1 		$2.59M Buy
21,721
+19,035
+709% +$2.45M 0.06% 300
2018
Q4 		$293K Sell
2,686
-11,045
-80% -$1.38M 0.01% 741
2018
Q3 		$2.22M Buy
+13,731
New +$1.88M 0.06% 351
2018
Q1 		– Sell
-42,631
Closed -$2.37M – 942
2017
Q4 		$2.37M Buy
42,631
+7,659
+22% +$406K 0.07% 315
2017
Q3 		$1.59M Buy
+34,972
New +$1.4M 0.05% 384

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BOK Financial's SRPT Position: Q3 2025 in Review

BOK Financial sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 1 share — an estimated $17 sold.

BOK Financial first reported a position in SRPT in Q3 2017 and held it in 20 quarters. The position peaked at $4.99M in Q4 2020. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • BOK Financial reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • BOK Financial sold 1 Sarepta Therapeutics share in Q3 2025, an estimated $17.
  • BOK Financial first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 20 quarters.
  • BOK Financial's Sarepta Therapeutics position peaked at $4.99M in Q4 2020.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on BOK Financial's 13F filing for Q3 2025, filed 13 Nov 2025.